Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →21
🟡 Moderate
Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
7,317
Total Claims
$584K
Drug Cost
456
Beneficiaries
$1,280
Cost/Patient
Risk Score Breakdown 21/100
Score components are additive. Read full methodology
Peer Comparison vs. 7,404 Physical Medicine and Rehabilitation providers
+186%
Opioid rate vs peers
57.7% vs 20.2% avg
+181%
Cost per patient vs peers
$1,280 vs $455 avg
+127%
Brand preference vs peers
7.1% vs 3.1% avg
⚠️ Opioid + Benzodiazepine Co-Prescriber
This provider prescribes both opioids and benzodiazepines. The FDA has issued a Black Box Warning about the life-threatening risks of concurrent use.
Opioid Prescribing
57.7%
Opioid Rate
4,224
Opioid Claims
$364K
Opioid Cost
25.8%
Long-Acting Rate
This provider's opioid prescribing rate of 57.7% is above the 20% threshold that CMS considers elevated.
Brand vs Generic
Brand: 520 claims · $304K
Generic: 6,779 claims · $275K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Oxycodone Myristate | 60 | $78K |
| Oxycodone Hcl | 70 | $74K |
| Methylnaltrexone Bromide | 26 | $48K |
| Hydrocodone/Acetaminophen | 1,048 | $36K |
| Oxycodone Hcl | 768 | $29K |
| Oxycodone Hcl/Acetaminophen | 620 | $27K |
| Buprenorphine Hcl/Naloxone Hcl | 89 | $26K |
| Buprenorphine Hcl | 45 | $25K |
| Fentanyl | 187 | $21K |
| Buprenorphine | 62 | $17K |
| Gabapentin | 677 | $16K |
| Morphine Sulfate | 513 | $15K |
| Naloxegol Oxalate | 33 | $15K |
| Pregabalin | 336 | $14K |
| Morphine Sulfate | 276 | $14K |
Prescribing Profile
51
Unique Drugs
21.0
Anomaly Score
Patient Profile
68
Avg Age
56%
Female
1.55
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About